Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
13 Settembre 2023 - 12:06PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-163
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of September 2023
Alterity
Therapeutics Limited
(Name
of Registrant)
Level
3, 460 Bourke Street, Melbourne, VIC 3000, Australia
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
This
Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073,
333-248980 and 333-228671)
and our Registration Statements on Form F-3 (Files No. 333-251647,
333-249311, 333-231417
and 333-250076)
ALTERITY
THERAPEUTICS LIMITED
(a
development stage enterprise)
The
following exhibits are submitted:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
Alterity Therapeutics Limited |
|
|
|
/s/ Geoffrey P. Kempler |
|
By: |
Geoffrey P. Kempler |
|
|
Chairman |
Date:
september 13, 2023
2
Exhibit 99.1
|
Notification of cessation of +securities |
Announcement
Summary
Entity name
ALTERITY THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday September 13, 2023
Details of +securities that have ceased
ASX+security code |
|
Security
description |
|
Number of
+securities that
have ceased |
|
The +securities have ceased
due to |
|
Date of
cessation |
|
|
|
|
|
|
|
|
|
ATHAAG |
|
OPTION EXPIRING
29-NOV-2026 EX $0.0238 |
|
500,000 |
|
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied |
|
11/09/2023 |
Refer to next page for full details of the announcement
Notification of cessation of +securities | 1/4 | |
|
Notification of cessation of +securities |
Part 1 - Announcement Details
1.1
Name of +Entity
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) provide the following information
about our issued capital.
|
1.2 Registered Number Type |
|
Registration Number |
|
|
|
|
|
ABN |
|
37080699065 |
1.3
ASX issuer code
ATH
1.4
The announcement is
þ
New announcement
1.5
Date of this announcement
13/9/2023
Notification of cessation of +securities | 2/4 | |
|
Notification of cessation of +securities |
Part 2 - Details of +equity securities or +debt securities that have
ceased
ASX +Security Code and Description
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238
Unquoted +equity securities that have ceased
Number of securities that have ceased
500,000
Reason for cessation
Lapse of conditional right to securities because the
conditions have not been, or have become incapable of being, satisfied
|
Date of cessation |
|
Is the entity paying any consideration for the cessation? |
|
|
|
|
|
11/9/2023 |
|
þ No |
Any other information the entity wishes to notify to
ASX about the cessation?
Notification of cessation of +securities | 3/4 | |
|
Notification of cessation of +securities |
Part 3 - Issued capital following changes
Following the cessation of
the + securities the subject of this notification, the issued capital of the entity will comprise:
3.1
Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description | |
| Total number of
+securities on issue | |
| |
| | |
ATH : ORDINARY FULLY PAID | |
| 2,439,897,618 | |
3.2
Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description | |
Total number of +securities on issue | |
| |
| |
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | |
| 19,250,000 | |
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 | |
| 12,000,000 | |
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | |
| 11,900,000 | |
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | |
| 35,000,000 | |
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 | |
| 674,694,939 | |
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | |
| 91,392,720 | |
Note: the figures stated in the tables above are used
to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes
of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the
entity has advised ASX of a change to that class of +security in Part 2 of this form.
Notification of cessation of +securities | 4/4 | |
Grafico Azioni Alterity Therapeutics (NASDAQ:ATHE)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Alterity Therapeutics (NASDAQ:ATHE)
Storico
Da Giu 2023 a Giu 2024